Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Kortex Ventures

Profile, fund size and portfolio

Parent Fleury, Sabin and Bradesco SaudeHQ BrazilFounded 2020

Kortex Ventures is the corporate venture arm of Fleury, Sabin and Bradesco Saude, a healthcare company. It was founded in 2020 and is based in Brazil. It invests at the Series A stage. Sectors it names: healthcare and digital health.

Fund sizeS1
USD 50M

Every figure links to its source

Snapshot

Investment stage: Series A to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series A
SectorsHealthcare and digital health
GeographyLatin America

Sources: S1 Global Venturing: Kortex Ventures three-LP fund.

Graphic 1 of 2

Investment stage: Series A to Series A

Sources: S1 Global Venturing: Kortex Ventures three-LP fund.

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 50MFund sizeStated by the firm or its parentS1
Companies on the firm's portfolio page5companiesCounted from the firm's own listS1

Sources: S1 Global Venturing: Kortex Ventures three-LP fund.

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Global Venturing: Kortex Ventures three-LP fund.

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Brazil

Investment regionsS1

LeadersS1

Kortex Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companyFleury, Sabin and Bradesco SaudeSingle sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2020Single sourceS2
HeadquartersBrazilSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent and outside investorsSingle sourceS1
Headline sizeUSD 50M (Fund size)Single sourceS1
StagesSeries ASingle sourceS1

Fund vehicles

VehicleSizeYearSource
Kortex Ventures fund IUSD 50M2022S1

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2024-05-07BiologixNot statedUSD 1.2MYesS3
2022-03-07KlivoSeries ABRL 50MNoS4

History

  1. Fleury and Sabin announced the Kortex CVC fund on 2020-11-04 and 2020-11-05, with up to BRL 200 million over 10 years and a 70% Fleury and 30% Sabin split.S2
  2. Bradesco Saude joined as a limited partner in 2022, taking a 23% stake; Fleury holds 54% and Sabin 23%, per Global Venturing.S1

Portfolio

Public sources name 5 portfolio companies.S1

Every company on the Kortex Ventures list

5 companies, as named in the sources cited.S1 Read the firm's list.

  • Biologix
  • Huna
  • ISA
  • Klivo
  • Sweetch

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Global Venturing: Kortex Ventures three-LP fundPress
  2. S2Medicina S/A: Grupo Sabin e Fleury criam fundo de venture capital para healthtechsPress
  3. S3LatamList: Brazilian healthtech Biologix lands a $1.2M roundPress
  4. S4Startupi: Klivo estende Serie A com Yaya Capital e Kortex VenturesPress
  5. S5Global Venturing: GVR Podcast, Kortex Ventures juggles three corporates to improve healthcarePress
  6. S6Epoca Negocios: Kortex Ventures entrevista BiologixPress

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Kortex Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.